Tretinoin/Oxaliplatin

维A酸/奥沙利铂

Report date: 2025/07/30 14:53:56
NME

Base Information

Drug NameTretinoin/Oxaliplatin
Drug Alias NameMROP
ClassificationSmall molecules
Mechanisms of ActionRetinoic acid receptor gamma agonistsRetinoic acid receptor beta agonistsRetinoic acid receptor alpha agonists +[4] 
TargetsRetinoic acid receptor gammaRetinoic acid receptor betaRetinoic acid receptor alpha +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes TretinoinOxaliplatin
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Science And Technology Of China
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Science And Technology Of China
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A